Flagship explainer

What drives Insight Molecular Diagnostics Inc.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity230%Tax burden100%net income ÷ pretax incomeInterest burden98%pretax ÷ operating incomeOperating margin−1261%operating income ÷ revenueAsset turnover0.13×revenue ÷ average assetsEquity multiplier-1.39×average assets ÷ average equityAs of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
−$50.2MFY2025
Income before tax−$50.2MFY2025
Operating income−$51.1MFY2025
$4.1MFY2025
Ending assets$25.8MFY2025
Beginning assets$35.1MFY2024
−$31.5MFY2025
−$12.3MFY2024
Source: · event Dec 31, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full Insight Molecular Diagnostics Inc. analysis at Buy Like Buffett